I agree it is not the 'blockbuster' announcement we are waiting for but SI has been very clear that their primary focus is reaching approval and commercialisation of Ryoncil for avghd. This is one of the very last hurdles in that strategy and is an incredible milestone.
- Forums
- ASX - By Stock
- Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
I agree it is not the 'blockbuster' announcement we...
-
- There are more pages in this discussion • 841 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.28 |
Change
-0.030(2.29%) |
Mkt cap ! $1.461B |
Open | High | Low | Value | Volume |
$1.32 | $1.35 | $1.28 | $1.677M | 1.289M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 44452 | $1.28 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.29 | 23596 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 44452 | 1.280 |
7 | 57207 | 1.275 |
5 | 132293 | 1.270 |
5 | 48028 | 1.265 |
9 | 82627 | 1.260 |
Price($) | Vol. | No. |
---|---|---|
1.290 | 23596 | 1 |
1.300 | 86052 | 3 |
1.305 | 161974 | 6 |
1.310 | 15842 | 3 |
1.315 | 36098 | 3 |
Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |